BioNTech SE (BNTX) EBIT Margin Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -4,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -453,860.00 |
| Sep 30, 2025 | -393.00 |
| Jun 30, 2025 | 275,359.00 |
| Mar 31, 2025 | 321,089.00 |
| Dec 31, 2024 | 446,745.00 |
| Sep 30, 2024 | -732.00 |
| Jun 30, 2024 | -260,983.00 |
| Mar 31, 2024 | -556,429.00 |
| Dec 31, 2023 | -4,139.00 |
| Sep 30, 2023 | -6,081.00 |
| Jun 30, 2023 | -40,502.00 |
| Mar 31, 2023 | -2,331.00 |
| Dec 31, 2022 | -798.00 |
| Sep 30, 2022 | -862.00 |
| Jun 30, 2022 | -996.00 |
| Mar 31, 2022 | -659.00 |
| Dec 31, 2021 | 1,425.00 |
| Sep 30, 2021 | -19,855.00 |
| Jun 30, 2021 | -11,463.00 |
| Mar 31, 2021 | -13,293.00 |
| Sep 30, 2020 | 14,750.00 |
| Jun 30, 2020 | 808.00 |
| Mar 31, 2020 | 4,648.00 |
| Sep 30, 2019 | 12,865.00 |